drugset / Trial / NCT05953142

Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.

NCT05953142

Phase 2 Unknown 120 enrolled Federal University of São Paulo
RandomizedSingle-groupOpen-labelTreatment

Summary

This phase 2 study aim to investigate the effect of dobutamine in patients with sepsis/ septic shock after fluid resuscitation and with hypoperfusion (lactate and central venous oxygen saturation or prolonged capillary refill time) on renal function as compared with usual care.

Timeline

Start
2024-02-01
Primary completion
2025-12-31
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dobutamine Small molecule Intravenous